Lab-Grown "Potato Cells": A Milestone in Building Life from Scratch
Release time:
2026-07-10
A droplet barely visible to the naked eye, encased in a lipid membrane and packed with chemical reagents and a strand of DNA containing just 36 genes—it is no product of nature, yet it stands as humanity’s closest approximation yet to "creating something from nothing." Recently, a team led by Kate Adamala at the University of Minnesota Twin Cities unveiled their synthetic cell system, dubbed "SpudCell," in the journal Biophys. Capable of "growing" via droplet fusion, replicating its genome, and even dividing through external triggers, SpudCell is hailed by the academic community as a landmark breakthrough in synthetic biology.
Breakthrough: Integrating Core Life Functions for the First Time
For years, research into artificial cells remained largely confined to mimicking single functions—such as synthesizing proteins within a droplet or simulating membrane exchange. The true challenge lay in orchestrating a complete life cycle of "growth, replication, and division" within one system, as different biochemical reactions demand wildly divergent conditions: some require acidity, others specific ion concentrations, making co-existence difficult.
SpudCell’s innovation lies in its successful integration of multiple core functional modules within a single liposome structure. Leveraging the established PURE system—a "starter kit" of biomolecules including ribosomes and enzymes—the team engineered special surface markers via molecular design. One marker binds to nutrient-carrying microvesicles, allowing the droplet to "feed" and accumulate biomass. Another interacts with streptavidin; once this molecule reaches a threshold concentration in the culture medium, the resulting repulsive force "pinches" the droplet into two, achieving division.
Crucially, SpudCell’s genome comprises a mere 90,000 base pairs—smaller than the theoretically predicted "minimal genome" for a living cell (113,000 base pairs) and organized across seven independent plasmids. This modular architecture allows scientists to "reprogram" life much like software, tweaking individual plasmids to enhance nutrient uptake or optimize fission efficiency.
Limitations: A Vast Chasm from "True Life"
Despite the excitement, the scientific community remains cautious regarding its status as a "living entity." Firstly, SpudCell’s division is heavily reliant on external intervention; natural division rates are abysmally low, with multi-round divisions requiring mechanical squeezing through microfabricated membranes. Secondly, genomic partitioning is erratic—after just five divisions, only 30% of daughter cells retain all seven plasmids. Furthermore, internal ribosomes—the core machinery for protein synthesis—degrade over time. Since SpudCell cannot synthesize new ribosomes or recycle old ones, its long-term viability is fundamentally constrained.
Significance: Bridging the Gap from "Simulation" to "Application"
Even with these limitations, SpudCell’s value is widely acknowledged. Drew Endy of Stanford calls it a "landmark pivot"—proof that integrating four or five core modules from disparate studies can yield a system capable of rudimentary autonomous growth and division. More importantly, it suggests the nascent emergence of evolutionary logic within a fully synthetic chemical framework.
The Adamala team notes that every component of SpudCell functions via well-understood mechanisms, providing a clear roadmap for optimization. Future efforts—such as consolidating the seven plasmids into a single, stable genome and engineering autonomous ribosome-assembly lines—could pave the way for applications in molecular medicine.
From "simulating life" to "creating it," humanity has journeyed for decades. SpudCell may not be the final destination, but the spark it ignites is illuminating a new path for synthetic biology toward real-world utility.
Previous article
Previous article
Latest developments
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
According to the latest announcement from the International Society of Cryobiology, Professor Xu Yi from the School of Health Science and Engineering at the University of Shanghai for Science and Technology, and a member of the Yinfeng Cryomedicine Expert Committee, has been elected as a Board Governor of the Society for a three-year term (2026–2028). The election was conducted through a democratic vote by all members worldwide, with three new Board Governors elected. Professor Xu Yi is the only scholar from Asia elected to the Society’s Board of Governors this time and the third elected scholar from mainland China in the Society’s 60-year history.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
